Abstract Background Poor clinical trial enrollment continues to be pervasive and is especially problematic among young adults and youth, and among minorities. Efforts to address barriers to enrollment have been predominantly focused on adult diseased populations. Because older adults may already have established attitudes, it is imperative to identify strategies that target adolescents and young adults. The purpose of this study was to test the effectiveness of an educational video on factors related to clinical trial participation among a healthy adolescent and young adult population. Methods Participants completed a 49-item pre-tes...
Drug development is a tedious process involving a huge amount of time and money. Clinical trials are...
Adolescents and young adults remain underrepresented in clinical trials. Knowledge and perceptions r...
The reasons why teenagers and young adults with cancer do, or do not, participate in clinical trials...
Abstract Background Poor clinical trial enrollment continues to be pervasive and is especially probl...
Background: Poor clinical trial enrollment continues to be pervasive and is especially problematic a...
Introduction: Innovative methods to increase awareness about clinical trials and address barriers as...
IntroductionOnly 3 to 5% of new adult cancer patients participate in clinical trials nationwide. The...
Background Advances in clinical care depend on well-designed clinical trials, yet the number of adul...
Brian D Friend,1 Abinav Baweja,2 Gary Schiller,3 Jonathan Bergman,4 Mark S Litwin,4 Jonathan W Goldm...
Purpose: Adolescents and young adults (AYAs) aged 15-39 at diagnosis have very low cancer clinical t...
Survival among adolescents and young adults (AYAs) ages 15 to 39 with cancer has not improved to the...
Purpose: Although cancer clinical trials (CT) offer opportunities for novel treatments that may lead...
BACKGROUNDPoor accrual to cancer clinical trials may contribute to the lower improvement in survival...
Victoria Forcina,1 Branavan Vakeesan,1 Chelsea Paulo,1 Laura Mitchell,1 Jennifer AH Bell,2 Seline Ta...
This is a report of a cluster randomized clinical trial evaluating the effectiveness of a church-bas...
Drug development is a tedious process involving a huge amount of time and money. Clinical trials are...
Adolescents and young adults remain underrepresented in clinical trials. Knowledge and perceptions r...
The reasons why teenagers and young adults with cancer do, or do not, participate in clinical trials...
Abstract Background Poor clinical trial enrollment continues to be pervasive and is especially probl...
Background: Poor clinical trial enrollment continues to be pervasive and is especially problematic a...
Introduction: Innovative methods to increase awareness about clinical trials and address barriers as...
IntroductionOnly 3 to 5% of new adult cancer patients participate in clinical trials nationwide. The...
Background Advances in clinical care depend on well-designed clinical trials, yet the number of adul...
Brian D Friend,1 Abinav Baweja,2 Gary Schiller,3 Jonathan Bergman,4 Mark S Litwin,4 Jonathan W Goldm...
Purpose: Adolescents and young adults (AYAs) aged 15-39 at diagnosis have very low cancer clinical t...
Survival among adolescents and young adults (AYAs) ages 15 to 39 with cancer has not improved to the...
Purpose: Although cancer clinical trials (CT) offer opportunities for novel treatments that may lead...
BACKGROUNDPoor accrual to cancer clinical trials may contribute to the lower improvement in survival...
Victoria Forcina,1 Branavan Vakeesan,1 Chelsea Paulo,1 Laura Mitchell,1 Jennifer AH Bell,2 Seline Ta...
This is a report of a cluster randomized clinical trial evaluating the effectiveness of a church-bas...
Drug development is a tedious process involving a huge amount of time and money. Clinical trials are...
Adolescents and young adults remain underrepresented in clinical trials. Knowledge and perceptions r...
The reasons why teenagers and young adults with cancer do, or do not, participate in clinical trials...